Cargando…

Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells

Esophageal adenocarcinoma (EAC) is a highly lethal cancer type with an overall poor survival rate. Twenty to thirty percent of EAC overexpress the human epidermal growth factor receptor 2 (Her2), a transmembrane receptor tyrosine kinase promoting cell growth and proliferation. Patients with Her2 ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janser, Félice A., Adams, Olivia, Bütler, Vanessa, Schläfli, Anna M., Dislich, Bastian, Seiler, Christian A., Kröll, Dino, Langer, Rupert, Tschan, Mario P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213363/ https://www.ncbi.nlm.nih.gov/pubmed/30297650 http://dx.doi.org/10.3390/ijms19103069

Ejemplares similares

Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2016)

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2019)

A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2018)

Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction
por: Dislich, Bastian, et al.
Publicado: (2022)

Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung
por: Losmanová, Tereza, et al.
Publicado: (2020)

Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”
por: Losmanová, Tereza, et al.
Publicado: (2021)

Favourable long-term survival of patients with esophageal cancer treated with extended transhiatal esophagectomy combined with en bloc lymphadenectomy: results from a retrospective observational cohort study
por: Kröll, Dino, et al.
Publicado: (2020)

Epstein–Barr Virus in Gastro-Esophageal Adenocarcinomas – Single Center Experiences in the Context of Current Literature
por: Genitsch, Vera, et al.
Publicado: (2015)

Reliable LC3 and p62 Autophagy Marker Detection in Formalin Fixed Paraffin Embedded Human Tissue by Immunohistochemistry
por: Schläfli, A.M., et al.
Publicado: (2015)

Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer
por: Schläfli, Anna M., et al.
Publicado: (2016)

Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity
por: Brigger, D, et al.
Publicado: (2015)

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
por: Liu, Drolaiz H. W., et al.
Publicado: (2023)

The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells
por: Schläfli, Anna M., et al.
Publicado: (2017)

The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment
por: Niklaus, Nicolas J., et al.
Publicado: (2021)

Interspatial Distribution of Tumor and Immune Cells in Correlation with PD-L1 in Molecular Subtypes of Gastric Cancers
por: Dislich, Bastian, et al.
Publicado: (2022)

Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer
por: Niklaus, Monique, et al.
Publicado: (2017)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells
por: Schläfli, Anna M., et al.
Publicado: (2021)

Expression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas
por: Langer, Rupert, et al.
Publicado: (2018)

The dynamics of HER2 status in esophageal adenocarcinoma
por: Creemers, Aafke, et al.
Publicado: (2018)

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2014)

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation
por: Schläfli, Anna M, et al.
Publicado: (2012)

Profiles of autophagy-related genes in esophageal adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2020)

Low Autophagy (ATG) Gene Expression Is Associated with an Immature AML Blast Cell Phenotype and Can Be Restored during AML Differentiation Therapy
por: Jin, Jing, et al.
Publicado: (2018)

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2019)

Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis
por: Creemers, A., et al.
Publicado: (2017)

Isoform-specific, Semi-quantitative Determination of Highly Homologous Protein Levels via CRISPR-Cas9-mediated HiBiT Tagging
por: Seiler, Kristina, et al.
Publicado: (2023)

NOD2 inhibits the proliferation of esophageal adenocarcinoma cells through autophagy
por: Li, Xiaozhi, et al.
Publicado: (2022)

The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
por: Dislich, Bastian, et al.
Publicado: (2012)

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
por: Djavaheri-Mergny, Mojgan, et al.
Publicado: (2019)

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
por: Plum, Patrick Sven, et al.
Publicado: (2019)

Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes
por: Duan, Lili, et al.
Publicado: (2021)

Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma
por: Xu, Tianfu, et al.
Publicado: (2021)

High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
por: Rauser, Sandra, et al.
Publicado: (2010)

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
por: HUANG, JUN-XING, et al.
Publicado: (2013)

Adversarial attacks and adversarial robustness in computational pathology
por: Ghaffari Laleh, Narmin, et al.
Publicado: (2022)

Assessing Autophagy in Archived Tissue or How to Capture Autophagic Flux from a Tissue Snapshot
por: Humbert, Magali, et al.
Publicado: (2020)

Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2020)

Chemoprevention of esophageal adenocarcinoma
por: Snider, Erik J, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
por: Aichler, Michaela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t04oactmdk806befqb2297e854